Undetected factor VIII in a patient with type 3 von willebrands disease mistaken as severe haemophilia A

Haemophilia

Volumn 15, Issue 6, 2009, Pages 1258-1261

  Mullah ali, M A ^a   Chan, A K ^a   Lillicrap, D ^b   Decker, K ^c   Seroski, W ^c   Moffat, K ^a   Walker, I ^a   Pai, M K ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Factor VIII level; Severe haemophilia A; Type 3 von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 8; RISTOCETIN; RISTOCETIN COFACTOR; UNCLASSIFIED DRUG;

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CASE REPORT; CIRCUMCISION; CONSANGUINEOUS MARRIAGE; DIAGNOSTIC ERROR; DISEASE SEVERITY; DNA DETERMINATION; DRUG HALF LIFE; ERYTHROCYTE TRANSFUSION; FAMILY HISTORY; GENE MUTATION; HEMOPHILIA A; HUMAN; LABORATORY TEST; MALE; NEWBORN; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

CIRCUMCISION, MALE; DIAGNOSTIC ERRORS; FACTOR VIII; FEMALE; GENES, RECESSIVE; GENOTYPE; HEMOPHILIA A; HEMOSTATICS; HUMANS; INFANT; MALE; PEDIGREE; POSTOPERATIVE HEMORRHAGE; VON WILLEBRAND DISEASE, TYPE 3; VON WILLEBRAND FACTOR;

EID: 70449568469     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02062.x     Document Type: Article

References (18)

1. Sadler JE, Mannucci PM, Berntorp E. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000, 84:160-74.
2. Miller CH, Lenzi R, Breen C. Prevalence of von Willebrand's disease among US adults. Blood 1987, 70n(Suppl. 1):377a.
3. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993, 123:893-8.
4. Ziv O, Ragni MV. Bleeding manifestations in males with von Willebrand disease. Haemophilia 2004, 10:162-8.
5. Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987, 70:895-904.
6. Eikenboom JC. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. Best Pract Res Clin Haematol 2001, 14:365-79.
7. Federici AB. Clinical diagnosis of von Willebrand disease. Haemophilia 2004, 10(Suppl. 4):169-76.
8. Nichols WC, Ginsburg D. von Willebrand disease. Medicine 1997, 76:1-20.
9. Federici AB. The factor VIII/von Willebrand factor complex: basic and clinical issues. Haematologica 2003, 88:EREP02.
10. Federici AB, Mazurier C, Bertorp E. Biologic response to desmopressin in patients with severe types 1 and 2 von Willebrand Disease: results of a multicenter prospective European study. Blood 2004, 103:2032-8.
11. Weiss HJ, Sussman I, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977, 60:390-404.
12. Koppelman SJ, Van Hoeij M, Vink T. Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C. Blood 1996, 87:2292-300.
13. Menache D, Aronson DL, Darr F. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups. Br J Haematol 1996, 94:740-5.
14. Zhang ZP, Lindstedt M, Falk G, Blombäck M, Egberg N, Anvret M. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I. Am J Hum Genet 1992, 51:850-8.
15. Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease. Br J Haematol 1995, 89:147-51.
16. Federici AB, Mannucci PM. Diagnosis and management of von Willebrand disease. Hemophilia 1999, 5:28-37.
17. Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol 2000, 111:1236-9.
18. Favaloro J, Lillicrap D, Lazzari MA. von Willebrand disease: laboratory aspects of diagnosis and treatment. Haemophilia 2004, 10(Suppl. 4):164-8.